Alignment Healthcare PE Ratio 2020-2025 | ALHC
Current and historical p/e ratio for Alignment Healthcare (ALHC) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Alignment Healthcare PE ratio as of August 28, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Alignment Healthcare PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-08-28 | 16.32 | 0.00 | |
2025-06-30 | 14.00 | $-0.28 | 0.00 |
2025-03-31 | 18.62 | $-0.48 | 0.00 |
2024-12-31 | 11.25 | $-0.68 | 0.00 |
2024-09-30 | 11.82 | $-0.77 | 0.00 |
2024-06-30 | 7.82 | $-0.82 | 0.00 |
2024-03-31 | 4.96 | $-0.84 | 0.00 |
2023-12-31 | 8.61 | $-0.79 | 0.00 |
2023-09-30 | 6.94 | $-0.85 | 0.00 |
2023-06-30 | 5.75 | $-0.88 | 0.00 |
2023-03-31 | 6.36 | $-0.79 | 0.00 |
2022-12-31 | 11.76 | $-0.82 | 0.00 |
2022-09-30 | 11.84 | $-0.78 | 0.00 |
2022-06-30 | 11.41 | $-0.82 | 0.00 |
2022-03-31 | 11.23 | $-1.01 | 0.00 |
2021-12-31 | 14.06 | $-1.15 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $3.232B | $2.704B |
Alignment Healthcare Inc. is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.998B | 27.26 |
CVS Health (CVS) | United States | $91.497B | 11.38 |
Elevance Health (ELV) | United States | $69.898B | 9.40 |
Cencora (COR) | United States | $56.203B | 18.72 |
DiDi Global (DIDIY) | China | $27.392B | 22.39 |
Natera (NTRA) | United States | $23.041B | 0.00 |
Labcorp Holdings (LH) | United States | $22.877B | 18.18 |
BioMerieux (BMXMF) | France | $17.423B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.582B | 0.00 |
ICON (ICLR) | Ireland | $14.136B | 13.60 |
Medpace Holdings (MEDP) | United States | $13.286B | 35.16 |
CochLear (CHEOY) | Australia | $12.819B | 0.00 |
Solventum (SOLV) | United States | $12.598B | 13.00 |
Viatris (VTRS) | United States | $12.137B | 4.32 |
Caris Life Sciences,�Inc (CAI) | United States | $10.751B | 0.00 |
Revvity (RVTY) | United States | $10.357B | 18.25 |
Avantor (AVTR) | United States | $9.006B | 13.21 |
Charles River Laboratories (CRL) | United States | $8.033B | 15.24 |
Sonic Healthcare (SKHHY) | Australia | $7.755B | 0.00 |
HealthEquity (HQY) | United States | $7.635B | 33.44 |
Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
Sotera Health (SHC) | United States | $4.602B | 25.71 |
BrightSpring Health Services (BTSG) | United States | $4.204B | 32.07 |
Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
GeneDx Holdings (WGS) | United States | $3.706B | 84.87 |
Concentras Parent (CON) | United States | $3.043B | 19.30 |
Surgery Partners (SGRY) | United States | $2.913B | 36.65 |
Organon (OGN) | United States | $2.386B | 2.60 |
KindlyMD (NAKA) | United States | $2.230B | 0.00 |
Premier (PINC) | United States | $2.169B | 20.05 |
Progyny (PGNY) | United States | $1.999B | 42.27 |
Ardent Health (ARDT) | United States | $1.793B | 6.92 |
PACS (PACS) | United States | $1.769B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.515B | 25.65 |
Pediatrix Medical (MD) | United States | $1.489B | 9.94 |
Teladoc Health (TDOC) | United States | $1.394B | 0.00 |
Omada Health (OMDA) | $1.360B | 0.00 | |
Establishment Labs Holdings (ESTA) | $1.188B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
Embecta (EMBC) | United States | $0.848B | 4.97 |
AMN Healthcare Services Inc (AMN) | United States | $0.768B | 9.50 |
CareDx (CDNA) | United States | $0.698B | 12.85 |
Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
Agilon Health (AGL) | United States | $0.526B | 0.00 |
InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.491B | 0.00 |
Nutex Health (NUTX) | United States | $0.491B | 7.43 |
Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
COMPASS Pathways (CMPS) | United Kingdom | $0.461B | 0.00 |
SBC Medicals (SBC) | United States | $0.424B | 9.27 |
Enhabit (EHAB) | United States | $0.401B | 26.40 |
So-Young (SY) | China | $0.399B | 0.00 |
Oncology Institute (TOI) | United States | $0.325B | 0.00 |
LifeMD (LFMD) | United States | $0.306B | 0.00 |
Beauty Health (SKIN) | United States | $0.259B | 0.00 |
Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.159B | 0.00 |
DocGo (DCGO) | United States | $0.159B | 0.00 |
Sera Prognostics (SERA) | United States | $0.116B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
Biodesix (BDSX) | United States | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.059B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
OSR Holdings (OSRH) | United States | $0.016B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
INVO Fertility (IVF) | United States | $0.004B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |